A Study for RNA (Genetic) Analysis in Adult Patients with Eosinophilic Esophagitis

Overview

About this study

The purpose of this study is to perform RNA (genetic) sequencing on biopsies taken from the esophagus of adult patients who have active eosinophilic esophagitis, and look for potential therapeutic targets.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adult patients older than 18 years
  • There will be three equal sized study groups
    • Normal controls
    • Patients with active Eosinophilic Esophagitis
    • Patients with active Eosinophilic Esophagitis who have been treated with steroids with improvement in symptoms  
  • Biopsies will be taken from mid and distal esophagus from those patients with Eosinophilic Esophagitis

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

David Katzka, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20271285

Mayo Clinic Footer